This gentle method allows patients to gradually acclimate to the medication, potentially minimizing side effects and enhancing overall treatment adherence
Unlike oral semaglutide, tirzepatides larger molecular size and chemical modifications currently pose significant challenges for the development of an effective oral formulation," Dr
Who Should NOT Use GLP-1 Medications GLP-1 medications are contraindicated for people with a personal or family history of medullary thyroid carcinoma, a personal or family history of MEN 2, a history of pancreatitis, severe gastrointestinal disease, current pregnancy or plans to become pregnant, or those currently breastfeeding
As you can see, the average weight loss is 7.59 pounds in the first month, 12.86 pounds over the first two months, 18.23 pounds over the first three months, 23.49 pounds over the first four months, 27.27 pounds over the first five months, 32.83 pounds over the first six months, 38.49 pounds over the first seven months and then 40.92 pounds over the first eight months
Yes, tirzepatide has been shown to slow gastric emptying in clinical studies
Patients with pre-existing gastrointestinal conditions, such as peptic ulcer disease or gastro-oesophageal reflux disease (GORD), should exercise particular caution
